AGP Executive Report
Last update: 5 hours agoCOVID-19 & Flu Watch: Hong Kong’s Centre for Health Protection says COVID-19 activity is rising again (one-year high) alongside seasonal influenza, urging strict personal and environmental hygiene and mask use for high-risk groups. Weight-loss Drugs in Focus: A Mainland China study looks at what drives acceptance of weight-loss drugs among overweight and obese adults, as obesity remains a major health concern. Macau Health Policy: Macau’s Health Bureau expands hepatitis B screening and follow-up, monitoring about 23,000 patients and targeting older residents as liver cancer risk stays high. Tobacco Control: Macau lawmakers back amendments to tighten e-cigarette rules and expand smoke-free areas, including around hospital and school entrances, with higher penalties for illegal emerging tobacco products. Wellness & Community: The 2026 Guangdong & Macao Branded Products Fair (6–9 Aug, Cotai Expo) spotlights “silver economy” and healthy living, with wellness product showcases and business matching. Local Health Infrastructure: Macau’s Productivity and Technology Transfer Centre marks 30 years, pushing digital transformation and certification support tied to health supplements and proprietary Chinese medicines. Gongbei Border Seizure: Zhuhai customs seized 600 weight-loss injection vials (tirzepatide) at the ZHMB checkpoint, warning against unregistered imports.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
